BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leclercq IA, Farrell GC, Sempoux C, dela Pena A, Horsmans Y. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol. 2004;41:926-934. [PMID: 15582125 DOI: 10.1016/j.jhep.2004.08.010] [Cited by in Crossref: 147] [Cited by in F6Publishing: 137] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa M. Curcumin and Health. Molecules 2016;21:264. [PMID: 26927041 DOI: 10.3390/molecules21030264] [Cited by in Crossref: 190] [Cited by in F6Publishing: 172] [Article Influence: 31.7] [Reference Citation Analysis]
2 Yan T, Yan N, Wang P, Xia Y, Hao H, Wang G, Gonzalez FJ. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharm Sin B 2020;10:3-18. [PMID: 31993304 DOI: 10.1016/j.apsb.2019.11.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
3 Wang ME, Chen YC, Chen IS, Hsieh SC, Chen SS, Chiu CH. Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes. J Nutr Biochem. 2012;23:1352-1366. [PMID: 22221674 DOI: 10.1016/j.jnutbio.2011.08.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
4 dela Peña A, Leclercq I, Field J, George J, Jones B, Farrell G. NF-κB Activation, Rather Than TNF, Mediates Hepatic Inflammation in a Murine Dietary Model of Steatohepatitis. Gastroenterology 2005;129:1663-74. [DOI: 10.1053/j.gastro.2005.09.004] [Cited by in Crossref: 200] [Cited by in F6Publishing: 202] [Article Influence: 11.8] [Reference Citation Analysis]
5 Jiang M, Wu N, Chen X, Wang W, Chu Y, Liu H, Li W, Chen D, Li X, Xu B. Pathogenesis of and major animal models used for nonalcoholic fatty liver disease. J Int Med Res 2019;47:1453-66. [PMID: 30871397 DOI: 10.1177/0300060519833527] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
6 Thangapazham RL, Sharad S, Maheshwari RK. Skin regenerative potentials of curcumin. BioFactors 2013;39:141-9. [DOI: 10.1002/biof.1078] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
7 Crespo I, García-mediavilla MV, Almar M, González P, Tuñón MJ, Sánchez-campos S, González-gallego J. Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells. Food and Chemical Toxicology 2008;46:1555-69. [DOI: 10.1016/j.fct.2007.12.014] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 5.9] [Reference Citation Analysis]
8 Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β. Chem Biol Interact 2015;237:151-65. [PMID: 26093215 DOI: 10.1016/j.cbi.2015.06.019] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 11.4] [Reference Citation Analysis]
9 Zhou JY, Jiang ZA, Zhao CY, Zhen Z, Wang W, Nanji AA. Long-term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver. Alcohol Clin Exp Res. 2013;37:213-222. [PMID: 23009062 DOI: 10.1111/j.1530-0277.2012.01936.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
10 Lawless MW, O’Byrne KJ, Gray SG. Targeting oxidative stress in cancer. Expert Opin Ther Targets. 2010;14:1225-1245. [PMID: 20942747 DOI: 10.1517/14728222.2010.526933] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
11 Cunningham RP, Moore MP, Moore AN, Healy JC, Roberts MD, Rector RS, Martin JS. Curcumin supplementation mitigates NASH development and progression in female Wistar rats. Physiol Rep 2018;6:e13789. [PMID: 30009570 DOI: 10.14814/phy2.13789] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Vera-Ramirez L, Pérez-Lopez P, Varela-Lopez A, Ramirez-Tortosa M, Battino M, Quiles JL. Curcumin and liver disease. Biofactors. 2013;39:88-100. [PMID: 23303639 DOI: 10.1002/biof.1057] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
13 Chung MY, Mah E, Masterjohn C, Noh SK, Park HJ, Clark RM, Park YK, Lee JY, Bruno RS. Green Tea Lowers Hepatic COX-2 and Prostaglandin E2 in Rats with Dietary Fat-Induced Nonalcoholic Steatohepatitis. J Med Food 2015;18:648-55. [PMID: 25453513 DOI: 10.1089/jmf.2014.0048] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
14 Soliman GF, Rashed LA, Morsi H, Ibrahim W, Abdallah H, Bastawy N, Abdel Maksoud OM. Interrelation of liver vascularity to non-alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats. Life Sci 2019;222:175-82. [PMID: 30826497 DOI: 10.1016/j.lfs.2019.02.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sci 2021;271:119220. [PMID: 33592199 DOI: 10.1016/j.lfs.2021.119220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Kim M, Yang SG, Kim JM, Lee JW, Kim YS, Lee JI. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. Int J Mol Med. 2012;30:473-479. [PMID: 22710359 DOI: 10.3892/ijmm.2012.1029] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
17 Hebbard L, George J. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2011;8:35-44. [PMID: 21119613 DOI: 10.1038/nrgastro.2010.191] [Cited by in Crossref: 295] [Cited by in F6Publishing: 292] [Article Influence: 24.6] [Reference Citation Analysis]
18 Mukherjee D, Ahmad R. COX-2/iNOS regulation during experimental hepatic injury and its mitigation by cloudy apple juice. Int J Biol Macromol 2019;140:1006-17. [PMID: 31445146 DOI: 10.1016/j.ijbiomac.2019.08.180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Lu C, Hung Y, Hsieh P. Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver. European Journal of Pharmacology 2016;789:60-7. [DOI: 10.1016/j.ejphar.2016.07.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
20 Heritage M, Jaskowski L, Bridle K, Campbell C, Briskey D, Britton L, Fletcher L, Vitetta L, Subramaniam VN, Crawford D. Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice. World J Gastrointest Pathophysiol 2017; 8(2): 67-76 [PMID: 28573069 DOI: 10.4291/wjgp.v8.i2.67] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gorabi AM, Razi B, Aslani S, Abbasifard M, Imani D, Sathyapalan T, Sahebkar A. Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials. Cytokine 2021;143:155541. [PMID: 33934954 DOI: 10.1016/j.cyto.2021.155541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tian F, Zhang YJ, Li Y, Xie Y. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression. PLoS One 2014;9:e83819. [PMID: 24404139 DOI: 10.1371/journal.pone.0083819] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
23 Kessoku T, Kobayashi T, Tanaka K, Yamamoto A, Takahashi K, Iwaki M, Ozaki A, Kasai Y, Nogami A, Honda Y, Ogawa Y, Kato S, Imajo K, Higurashi T, Hosono K, Yoneda M, Usuda H, Wada K, Saito S, Nakajima A. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. Int J Mol Sci 2021;22:8161. [PMID: 34360923 DOI: 10.3390/ijms22158161] [Reference Citation Analysis]
24 Ninomiya M, Kondo Y, Shimosegawa T. Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis. ISRN Hepatol 2013;2013:237870. [PMID: 27335818 DOI: 10.1155/2013/237870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Parodi FE, Mao D, Ennis TL, Pagano MB, Thompson RW. Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms. Ann Vasc Surg 2006;20:360-8. [PMID: 16779518 DOI: 10.1007/s10016-006-9054-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
26 Lee GS, Yan JS, Ng RK, Kakar S, Maher JJ. Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury. J Lipid Res. 2007;48:1885-1896. [PMID: 17526933 DOI: 10.1194/jlr.M700181-JLR200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
27 Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2008;2:803-816. [PMID: 19090740 DOI: 10.1586/17474124.2.6.803] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 4.9] [Reference Citation Analysis]
28 Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology. 2006;43:163-172. [PMID: 16374858 DOI: 10.1002/hep.20999] [Cited by in Crossref: 289] [Cited by in F6Publishing: 284] [Article Influence: 18.1] [Reference Citation Analysis]
29 Park J, Shim Y, Kang B, Lee W, Min B. Hepatocyte-specific clusterin overexpression attenuates diet-induced nonalcoholic steatohepatitis. Biochemical and Biophysical Research Communications 2018;495:1775-81. [DOI: 10.1016/j.bbrc.2017.12.045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
30 Stanimirovic J, Obradovic M, Zafirovic S, Resanovic I, Bogdanovic N, Gluvic Z, Mousa SA, Isenovic ER. Effects of altered hepatic lipid metabolism on regulation of hepatic iNOS. Clinical Lipidology 2015;10:167-75. [DOI: 10.2217/clp.15.8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Maradana MR, Yekollu SK, Zeng B, Ellis J, Clouston A, Miller G, Talekar M, Bhuyan ZA, Mahadevaiah S, Powell EE, Irvine KM, Thomas R, O'Sullivan BJ. Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. Metabolism 2018;78:80-94. [PMID: 28941597 DOI: 10.1016/j.metabol.2017.09.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
32 Singh A, Yau YF, Leung KS, El-Nezami H, Lee JC. Interaction of Polyphenols as Antioxidant and Anti-Inflammatory Compounds in Brain-Liver-Gut Axis. Antioxidants (Basel) 2020;9:E669. [PMID: 32722619 DOI: 10.3390/antiox9080669] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
33 Uchio R, Murosaki S, Ichikawa H. Hot water extract of turmeric (Curcuma longa) prevents non-alcoholic steatohepatitis in mice by inhibiting hepatic oxidative stress and inflammation. J Nutr Sci 2018;7:e36. [PMID: 30627433 DOI: 10.1017/jns.2018.27] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
34 Bergoeing MP, Thompson RW, Curci JA. Pharmacological targets in the treatment of abdominal aortic aneurysms. Expert Opinion on Therapeutic Targets 2006;10:547-59. [DOI: 10.1517/14728222.10.4.547] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
35 Peng C, Stewart AG, Woodman OL, Ritchie RH, Qin CX. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. Front Pharmacol 2020;11:603926. [PMID: 33343375 DOI: 10.3389/fphar.2020.603926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
36 Zhao NJ, Liao MJ, Wu JJ, Chu KX. Curcumin suppresses Notch‑1 signaling: Improvements in fatty liver and insulin resistance in rats. Mol Med Rep 2018;17:819-26. [PMID: 29115530 DOI: 10.3892/mmr.2017.7980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
37 Da Silva Morais A, Lebrun V, Abarca-Quinones J, Brichard S, Hue L, Guigas B, Viollet B, Leclercq IA. Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation. J Hepatol 2009;50:489-500. [PMID: 19155087 DOI: 10.1016/j.jhep.2008.10.027] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
38 Zhao L, Du M, Gao J, Zhan B, Mao X. Label-free quantitative proteomic analysis of milk fat globule membrane proteins of yak and cow and identification of proteins associated with glucose and lipid metabolism. Food Chemistry 2019;275:59-68. [DOI: 10.1016/j.foodchem.2018.09.044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
39 Wasmuth HE, Zaldivar MM, Beraza N, Trautwein C. Of mice and NASH – from fat to inflammation and fibrosis. Drug Discovery Today: Disease Models 2007;4:25-30. [DOI: 10.1016/j.ddmod.2007.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Leclercq IA, Vansteenberghe M, Lebrun VB, Vanhul NK, Abarca-quinones J, Sempoux CL, Picard C, Stärkel P, Horsmans YL. Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin. Lab Invest 2006;86:1161-71. [DOI: 10.1038/labinvest.3700474] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
41 Yan HJ, Kwon SY, Kim K, Jeong H, Kim Y, Chung WS, Lee J, Jang H. Anti-fibrotic effects of Kyungheechunggan-tang on activated hepatic stellate cells and rat liver. Mol Cell Toxicol 2014;10:411-21. [DOI: 10.1007/s13273-014-0046-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
42 Zhang S, Xu M, Zhang W, Liu C, Chen S. Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications. Int J Mol Sci 2021;22:6110. [PMID: 34204038 DOI: 10.3390/ijms22116110] [Reference Citation Analysis]
43 Leclercq IA, Lebrun VA, Stärkel P, Horsmans YJ. Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. Lab Invest. 2007;87:56-65. [PMID: 17075577 DOI: 10.1038/labinvest.3700489] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 4.8] [Reference Citation Analysis]
44 Pickich MB, Hargrove MW, Phillips CN, Healy JC, Moore AN, Roberts MD, Martin JS. Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis. BMC Res Notes 2019;12:496. [PMID: 31399137 DOI: 10.1186/s13104-019-4540-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Xiao H, Zhang JY, Zheng J. Resveratrol down-regulates hepatic cyclooxygenase-2 expression in mice with nonalcoholic steatohepatitis. Shijie Huaren Xiaohua Zazhi 2008; 16(19): 2092-2096 [DOI: 10.11569/wcjd.v16.i19.2092] [Reference Citation Analysis]
46 Park HJ, Han JM, Kim HG, Choi MK, Lee JS, Lee HW, Son CG. Chunggan extract (CGX), methionine-and choline-deficient (MCD) diet-induced hepatosteatosis and oxidative stress in C57BL/6 mice. Hum Exp Toxicol 2013;32:1258-69. [PMID: 23970447 DOI: 10.1177/0960327113485253] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
47 Vizzutti F, Provenzano A, Galastri S, Milani S, Delogu W, Novo E, Caligiuri A, Zamara E, Arena U, Laffi G. Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Lab Invest. 2010;90:104-115. [PMID: 19901911 DOI: 10.1038/labinvest.2009.112] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
48 Coban D, Milenkovic D, Chanet A, Khallou-Laschet J, Sabbe L, Palagani A, Vanden Berghe W, Mazur A, Morand C. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol Nutr Food Res 2012;56:1270-81. [PMID: 22753158 DOI: 10.1002/mnfr.201100818] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
49 Schwenger KJP, Ghorbani Y, Li C, Fischer SE, Jackson TD, Okrainec A, Allard JP. Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease in Obese Patients Undergoing Bariatric Surgery. OBES SURG 2020;30:2572-8. [DOI: 10.1007/s11695-020-04514-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Galastri S, Zamara E, Milani S, Novo E, Provenzano A, Delogu W, Vizzutti F, Sutti S, Locatelli I, Navari N. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. Clin Sci (Lond). 2012;123:459-471. [PMID: 22545719 DOI: 10.1042/cs20110515] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
51 Rajashekar Reddy CB, Rajasekhara Reddy S, Suthindhiran K, Sivakumar A. HDAC and NF-κB mediated cytotoxicity induced by novel N-Chloro β-lactams and benzisoxazole derivatives. Chem Biol Interact 2016;246:69-76. [PMID: 26776669 DOI: 10.1016/j.cbi.2016.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
52 Patel SS, Acharya A, Ray RS, Agrawal R, Raghuwanshi R, Jain P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit Rev Food Sci Nutr 2020;60:887-939. [PMID: 30632782 DOI: 10.1080/10408398.2018.1552244] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 20.0] [Reference Citation Analysis]
53 Zhang J, Zhang H, Deng X, Zhang N, Liu B, Xin S, Li G, Xu K. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. Life Sci. 2018;192:46-54. [PMID: 29158052 DOI: 10.1016/j.lfs.2017.11.027] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
54 Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken). 2008;291:684-692. [PMID: 18484615 DOI: 10.1002/ar.20715] [Cited by in Crossref: 166] [Cited by in F6Publishing: 159] [Article Influence: 11.9] [Reference Citation Analysis]
55 Durham WJ, Arbogast S, Gerken E, Li YP, Reid MB. Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice. Muscle Nerve 2006;34:298-303. [PMID: 16718687 DOI: 10.1002/mus.20579] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
56 Ito M, Suzuki J, Tsujioka S, Sasaki M, Gomori A, Shirakura T, Hirose H, Ito M, Ishihara A, Iwaasa H. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol Res. 2007;37:50-57. [PMID: 17300698 DOI: 10.1111/j.1872-034x.2007.00008.x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 75] [Article Influence: 11.8] [Reference Citation Analysis]
57 Lee IC, Lee SM, Ko JW, Park SH, Shin IS, Moon C, Kim SH, Kim JC. Role of mitogen-activated protein kinases and nuclear factor-kappa B in 1,3-dichloro-2-propanol-induced hepatic injury. Lab Anim Res 2016;32:24-33. [PMID: 27051440 DOI: 10.5625/lar.2016.32.1.24] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
58 Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med. 2008;14:72-81. [PMID: 18218340 DOI: 10.1016/j.molmed.2007.12.003] [Cited by in Crossref: 293] [Cited by in F6Publishing: 288] [Article Influence: 20.9] [Reference Citation Analysis]
59 Duval F, Moreno-Cuevas JE, González-Garza MT, Maldonado-Bernal C, Cruz-Vega DE. Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. Int J Inflam 2015;2015:943497. [PMID: 25954568 DOI: 10.1155/2015/943497] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
60 Saadati S, Sadeghi A, Mansour A, Yari Z, Poustchi H, Hedayati M, Hatami B, Hekmatdoost A. Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. BMC Gastroenterol. 2019;19:133. [PMID: 31345163 DOI: 10.1186/s12876-019-1055-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
61 Messner DJ, Rhieu BH, Kowdley KV. Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes. Dig Dis Sci. 2013;58:1899-1908. [PMID: 23558563 DOI: 10.1007/s10620-013-2648-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
62 Pierce AA, Duwaerts CC, Siao K, Mattis AN, Goodsell A, Baron JL, Maher JJ. CD18 deficiency improves liver injury in the MCD model of steatohepatitis. PLoS One 2017;12:e0183912. [PMID: 28873429 DOI: 10.1371/journal.pone.0183912] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
63 Federico A, Dallio M, Godos J, Loguercio C, Salomone F. Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. Transl Res. 2016;167:116-124. [PMID: 26318867 DOI: 10.1016/j.trsl.2015.08.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
64 Salehi E, Mashayekh M, Taheri F, Gholami M, Motaghinejad M, Safari S, Sepehr A. Curcumin Can be Acts as Effective agent for Prevent or Treatment of Alcohol-induced Toxicity in Hepatocytes: An Illustrated Mechanistic Review. Iran J Pharm Res 2021;20:418-36. [PMID: 34400970 DOI: 10.22037/ijpr.2020.112852.13985] [Reference Citation Analysis]
65 Hu YB. Mechanisms of non-alcoholic steatohepatitis: pathophysiology and molecular biology. Shijie Huaren Xiaohua Zazhi 2009; 17(13): 1329-1334 [DOI: 10.11569/wcjd.v17.i13.1329] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
66 Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res. 2008;49:1068-1076. [PMID: 18227531 DOI: 10.1194/jlr.m800042-jlr200] [Cited by in Crossref: 273] [Cited by in F6Publishing: 169] [Article Influence: 19.5] [Reference Citation Analysis]
67 Bruck R, Ashkenazi M, Weiss S, Goldiner I, Shapiro H, Aeed H, Genina O, Helpern Z, Pines M. Prevention of liver cirrhosis in rats by curcumin. Liver Int. 2007;27:373-383. [PMID: 17355460 DOI: 10.1111/j.1478-3231.2007.01453.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 5.9] [Reference Citation Analysis]
68 Zhang Y, Cui Y, Wang X, Shang X, Qi Z, Xue J, Zhao X, Deng M, Xie M. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. Cytokine 2015;75:127-35. [DOI: 10.1016/j.cyto.2015.05.031] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
69 Zhang J, Xu Y, Xiong W, Zhang Z, Du C, Qiao L, Ni W, Chen S. Inhibitory activity of nuclear factor-kappaB potentiates cisplatin-induced apoptosis in A549 cells. J Huazhong Univ Sci Technolog Med Sci 2008;28:251-6. [PMID: 18563317 DOI: 10.1007/s11596-008-0305-4] [Reference Citation Analysis]
70 Marra F, Lotersztajn S. Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des. 2013;19:5250-5269. [PMID: 23394092 DOI: 10.2174/1381612811399990344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Motiño O, Agra N, Brea Contreras R, Domínguez-moreno M, García-monzón C, Vargas-castrillón J, Carnovale CE, Boscá L, Casado M, Mayoral R, Valdecantos MP, Valverde ÁM, Francés DE, Martín-sanz P. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2016;1862:1710-23. [DOI: 10.1016/j.bbadis.2016.06.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
72 Schwartz JJ, Emerson L, Hillas E, Phan A, Thiesset H, Firpo M, Sorensen J, Kennedy T, Rinella M. Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative. Hepatol Int 2013;7:600-9. [PMID: 26201793 DOI: 10.1007/s12072-013-9426-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
73 Blondet NM, Messner DJ, Kowdley KV, Murray KF. Mechanisms of Hepatocyte Detoxification. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 981-1001. [DOI: 10.1016/b978-0-12-809954-4.00043-8] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
74 Jadeja R, Devkar RV, Nammi S. Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects. Evid Based Complement Alternat Med 2014;2014:648308. [PMID: 24987431 DOI: 10.1155/2014/648308] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
75 London RM, George J. Pathogenesis of NASH: Animal Models. Clinics in Liver Disease 2007;11:55-74. [DOI: 10.1016/j.cld.2007.02.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 4.7] [Reference Citation Analysis]
76 Ali BH, Marrif H, Noureldayem SA, Bakheit AO, Blunden G. Some Biological Properties of Curcumin: A Review. Natural Product Communications 2006;1:1934578X0600100. [DOI: 10.1177/1934578x0600100613] [Cited by in Crossref: 25] [Article Influence: 8.3] [Reference Citation Analysis]
77 Hofseth LJ. Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer. Cancer Lett. 2008;268:10-30. [PMID: 18440130 DOI: 10.1016/j.canlet.2008.03.024] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
78 Allam G. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Immunobiology 2009;214:712-27. [PMID: 19249123 DOI: 10.1016/j.imbio.2008.11.017] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 7.0] [Reference Citation Analysis]
79 Girish C, Pradhan SC. Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin. Fundam Clin Pharmacol 2008;22:623-32. [PMID: 19049667 DOI: 10.1111/j.1472-8206.2008.00618.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
80 Alwayn IP, Porte RJ. How to make steatotic livers suitable for transplantation. Liver Transpl 2007;13:480-2. [DOI: 10.1002/lt.21026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
81 Xiao S, Deng Y, Shen N, Sun Y, Tang H, Hu P, Ren H, Peng M. Curc-mPEG454, a PEGylated curcumin derivative, as a multi-target anti-fibrotic prodrug. Int Immunopharmacol 2021;101:108166. [PMID: 34628270 DOI: 10.1016/j.intimp.2021.108166] [Reference Citation Analysis]
82 Ramadori P, Weiskirchen R, Trebicka J, Streetz K. Mouse models of metabolic liver injury. Lab Anim 2015;49:47-58. [PMID: 25835738 DOI: 10.1177/0023677215570078] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
83 Kireev RA, Tresguerres AC, Garcia C, Borras C, Ariznavarreta C, Vara E, Vina J, Tresguerres JA. Hormonal regulation of pro-inflammatory and lipid peroxidation processes in liver of old ovariectomized female rats. Biogerontology 2010;11:229-43. [PMID: 19633997 DOI: 10.1007/s10522-009-9242-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
84 Yan SL, Yang HT, Lee YJ, Lin CC, Chang MH, Yin MC. Asiatic acid ameliorates hepatic lipid accumulation and insulin resistance in mice consuming a high-fat diet. J Agric Food Chem 2014;62:4625-31. [PMID: 24779966 DOI: 10.1021/jf501165z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
85 Farrell GC. The liver and the waistline: Fifty years of growth. J Gastroenterol Hepatol. 2009;24 Suppl 3:S105-S118. [PMID: 19799688 DOI: 10.1111/j.1440-1746.2009.06080.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
86 Jang SA, Lee S, Sohn EH, Yang J, Park DW, Jeong YJ, Kim I, Kwon JE, Song HS, Cho YM, Meng X, Koo HJ, Kang SC. Cynanchum wilfordii Radix attenuates liver fat accumulation and damage by suppressing hepatic cyclooxygenase-2 and mitogen-activated protein kinase in mice fed with a high-fat and high-fructose diet. Nutr Res 2016;36:914-24. [PMID: 27632911 DOI: 10.1016/j.nutres.2016.06.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
87 Kim YS, Ahn Y, Hong MH, Joo SY, Kim KH, Sohn IS, Park HW, Hong YJ, Kim JH, Kim W, Jeong MH, Cho JG, Park JC, Kang JC. Curcumin Attenuates Inflammatory Responses of TNF-α-Stimulated Human Endothelial Cells. Journal of Cardiovascular Pharmacology 2007;50:41-9. [DOI: 10.1097/fjc.0b013e31805559b9] [Cited by in Crossref: 95] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
88 Shapiro H, Bruck R. Therapeutic potential of curcumin in non-alcoholic steatohepatitis. Nutr Res Rev 2005;18:212-21. [DOI: 10.1079/nrr2005106] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
89 Nabavi SF, Daglia M, Moghaddam AH, Habtemariam S, Nabavi SM. Curcumin and Liver Disease: from Chemistry to Medicine: Curcumin and liver disease…. Comprehensive Reviews in Food Science and Food Safety 2014;13:62-77. [DOI: 10.1111/1541-4337.12047] [Cited by in Crossref: 97] [Cited by in F6Publishing: 59] [Article Influence: 10.8] [Reference Citation Analysis]
90 Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocr Rev. 2013;34:84-129. [PMID: 23238855 DOI: 10.1210/er.2012-1009] [Cited by in Crossref: 132] [Cited by in F6Publishing: 127] [Article Influence: 13.2] [Reference Citation Analysis]
91 Sancho P, Martín-Sanz P, Fabregat I. Reciprocal regulation of NADPH oxidases and the cyclooxygenase-2 pathway. Free Radic Biol Med 2011;51:1789-98. [PMID: 21907277 DOI: 10.1016/j.freeradbiomed.2011.08.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
92 Videla LA, Tapia G, Rodrigo R, Pettinelli P, Haim D, Santibañez C, Araya AV, Smok G, Csendes A, Gutierrez L, Rojas J, Castillo J, Korn O, Maluenda F, Díaz JC, Rencoret G, Poniachik J. Liver NF-κB and AP-1 DNA Binding in Obese Patients. Obesity 2009;17:973-9. [DOI: 10.1038/oby.2008.601] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
93 Hamid M, Abdulrahim Y, Liu D, Qian G, Khan A, Huang K. The Hepatoprotective Effect of Selenium-Enriched Yeast and Gum Arabic Combination on Carbon Tetrachloride-Induced Chronic Liver Injury in Rats. J Food Sci 2018;83:525-34. [PMID: 29350750 DOI: 10.1111/1750-3841.14030] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
94 Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl Res. 2012;159:477-486. [PMID: 22633099 DOI: 10.1016/j.trsl.2011.12.003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 7.9] [Reference Citation Analysis]
95 Liu XJ, Shen B, Du YJ. Role of cyclooxygenase-2 and matrix metalloproteinase-2 in nonalcoholic steatohepatitis of rats. Shijie Huaren Xiaohua Zazhi 2007; 15(9): 947-952 [DOI: 10.11569/wcjd.v15.i9.947] [Reference Citation Analysis]
96 Qiu L, Guo C. Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease. Curr Drug Targets 2020;21:599-609. [PMID: 31589122 DOI: 10.2174/1389450120666191007111712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
97 Anggakusuma , Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S, Behrendt P, Brown RJ, Bankwitz D, Steinmann J. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 2014;63:1137-1149. [PMID: 23903236 DOI: 10.1136/gutjnl-2012-304299] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 11.4] [Reference Citation Analysis]
98 Gambino R, Musso G, Cassader M. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2011;15:1325-1365. [PMID: 20969475 DOI: 10.1089/ars.2009.3058] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 8.8] [Reference Citation Analysis]
99 Liu Y, Li J, Liao L, Huang H, Fan S, Fu R, Huang J, Shi C, Yu L, Chen KX, Zhang YY, Luo C, Li GM. Cyclin-dependent kinase inhibitor roscovitine attenuates liver inflammation and fibrosis by influencing initiating steps of liver injury. Clin Sci (Lond) 2021;135:925-41. [PMID: 33786590 DOI: 10.1042/CS20201111] [Reference Citation Analysis]
100 Salomone F, Godos J, Zelber-Sagi S. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives. Liver Int. 2016;36:5-20. [PMID: 26436447 DOI: 10.1111/liv.12975] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 16.4] [Reference Citation Analysis]
101 Mollica G, Senesi P, Codella R, Vacante F, Montesano A, Luzi L, Terruzzi I. L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet. Dig Liver Dis 2020;52:314-23. [PMID: 31607566 DOI: 10.1016/j.dld.2019.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
102 Chen Y, Huang A, Ruan X. Nuclear transcription factors and lipid homeostasis in liver: . Chinese Medical Journal 2007;120:2290-6. [DOI: 10.1097/00029330-200712020-00026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
103 Zhou JY, Poudel A, Welchko R, Mekala N, Chandramani-Shivalingappa P, Rosca MG, Li L. Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways. Eur J Pharmacol 2019;861:172594. [PMID: 31412267 DOI: 10.1016/j.ejphar.2019.172594] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
104 Imajo K, Yoneda M, Ogawa Y, Wada K, Nakajima A. Microbiota and nonalcoholic steatohepatitis. Semin Immunopathol. 2014;36:115-132. [PMID: 24337650 DOI: 10.1007/s00281-013-0404-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
105 García-Niño WR, Pedraza-Chaverrí J. Protective effect of curcumin against heavy metals-induced liver damage. Food Chem Toxicol 2014;69:182-201. [PMID: 24751969 DOI: 10.1016/j.fct.2014.04.016] [Cited by in Crossref: 194] [Cited by in F6Publishing: 166] [Article Influence: 24.3] [Reference Citation Analysis]
106 Tian F, Fan T, Zhang Y, Jiang Y, Zhang X. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai) 2012;44:847-55. [PMID: 23017833 DOI: 10.1093/abbs/gms074] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
107 Wang X, Li L, Wang H, Xiao F, Ning Q. Epoxyeicosatrienoic acids alleviate methionine‐choline‐deficient diet–induced non‐alcoholic steatohepatitis in mice. Scand J Immunol 2019;90. [DOI: 10.1111/sji.12791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
108 Chen WJ, Cai B, Chen HT, Cao CY, Du YL, Li YY, Nie YQ, Zhou YJ. The role of ADIPOQ methylation in curcumin-administrated experimental nonalcoholic fatty liver disease: ADIPOQ methylation in NAFLD. Journal of Digestive Diseases 2016;17:829-36. [DOI: 10.1111/1751-2980.12431] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
109 Yu J, Ip E, Dela Pena A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. Hepatology. 2006;43:826-836. [PMID: 16557554 DOI: 10.1002/hep.21108] [Cited by in Crossref: 114] [Cited by in F6Publishing: 112] [Article Influence: 7.1] [Reference Citation Analysis]
110 Marra F, Lotersztajn S. Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des 2013;19:5250-69. [PMID: 23394092 DOI: 10.2174/13816128113199990344] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 11.8] [Reference Citation Analysis]
111 dela Peña A, Leclercq IA, Williams J, Farrell GC. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis. J Hepatol 2007;46:304-13. [PMID: 17157947 DOI: 10.1016/j.jhep.2006.08.025] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
112 García-Mediavilla V, Crespo I, Collado PS, Esteller A, Sánchez-Campos S, Tuñón MJ, González-Gallego J. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol. 2007;557:221-229. [PMID: 17184768 DOI: 10.1016/j.ejphar.2006.11.014] [Cited by in Crossref: 302] [Cited by in F6Publishing: 276] [Article Influence: 18.9] [Reference Citation Analysis]
113 Yan C, Zhang Y, Zhang X, Aa J, Wang G, Xie Y. Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice. Biomed Pharmacother 2018;105:274-81. [PMID: 29860219 DOI: 10.1016/j.biopha.2018.05.135] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 9.5] [Reference Citation Analysis]
114 Kumei S, Yuhki KI, Kojima F, Kashiwagi H, Imamichi Y, Okumura T, Narumiya S, Ushikubi F. Prostaglandin I2 suppresses the development of diet-induced nonalcoholic steatohepatitis in mice. FASEB J 2018;32:2354-65. [PMID: 29247122 DOI: 10.1096/fj.201700590R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
115 Yao H, Qiao YJ, Zhao YL, Tao XF, Xu LN, Yin LH, Qi Y, Peng JY. Herbal medicines and nonalcoholic fatty liver disease. World J Gastroenterol 2016; 22(30): 6890-6905 [PMID: 27570425 DOI: 10.3748/wjg.v22.i30.6890] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
116 Teoh NC, Williams J, Hartley J, Yu J, McCuskey RS, Farrell GC. Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury. Hepatology 2010;51:996-1006. [PMID: 20131406 DOI: 10.1002/hep.23420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
117 Shen C, Gao J, Zhao CY. Animal models of non-alcoholic fatty liver disease: recent advances. Shijie Huaren Xiaohua Zazhi 2009; 17(33): 3414-3419 [DOI: 10.11569/wcjd.v17.i33.3414] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
118 Dias KA, da Conceição AR, Oliveira LA, Pereira SMS, Paes SDS, Monte LF, Sarandy MM, Novaes RD, Gonçalves RV, Della Lucia CM. Effects of Curcumin Supplementation on Inflammatory Markers, Muscle Damage, and Sports Performance during Acute Physical Exercise in Sedentary Individuals. Oxid Med Cell Longev 2021;2021:9264639. [PMID: 34659641 DOI: 10.1155/2021/9264639] [Reference Citation Analysis]
119 Nan YM, Han F, Kong LB, Zhao SX, Wang RQ, Wu WJ, Yu J. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice. Scand J Gastroenterol 2011;46:358-69. [PMID: 20969493 DOI: 10.3109/00365521.2010.525717] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
120 Yu J, Chu ES, Hui AY, Cheung KF, Chan HL, Leung WK, Farrell GC, Sung JJ. Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis. Biochemical and Biophysical Research Communications 2007;356:53-9. [DOI: 10.1016/j.bbrc.2007.02.129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
121 Meng R, Zhu DL, Bi Y, Yang DH, Wang YP. Apocynin improves insulin resistance through suppressing inflammation in high-fat diet-induced obese mice. Mediators Inflamm 2010;2010:858735. [PMID: 21403905 DOI: 10.1155/2010/858735] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
122 Zhang Y, Hu Y, Li J, Chi Y, Jiang W, Zhang F, Liu Y. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles. Hepatobiliary & Pancreatic Diseases International 2017;16:65-79. [DOI: 10.1016/s1499-3872(16)60098-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
123 Marchesini G, Moscatiello S, Agostini F, Villanova N, Festi D. Treatment of non-alcoholic fatty liver disease with focus on emerging drugs. Expert Opin Emerg Drugs 2011;16:121-36. [PMID: 21352073 DOI: 10.1517/14728214.2011.531700] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
124 Caldwell SH, Ikura Y, Iezzoni JC, Liu Z. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)? J Gastroenterol Hepatol. 2007;22 Suppl 1:S11-S19. [PMID: 17567458 DOI: 10.1111/j.1440-1746.2006.04639.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
125 Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver. 2012;6:149-171. [PMID: 22570745 DOI: 10.5009/gnl.2012.6.2.149] [Cited by in Crossref: 247] [Cited by in F6Publishing: 231] [Article Influence: 24.7] [Reference Citation Analysis]
126 Platania CBM, Fidilio A, Lazzara F, Piazza C, Geraci F, Giurdanella G, Leggio GM, Salomone S, Drago F, Bucolo C. Retinal Protection and Distribution of Curcumin in Vitro and in Vivo. Front Pharmacol 2018;9:670. [PMID: 30013474 DOI: 10.3389/fphar.2018.00670] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
127 Messner DJ, Sivam G, Kowdley KV. Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells. Liver Int. 2009;29:63-72. [PMID: 18492020 DOI: 10.1111/j.1478-3231.2008.01793.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
128 Li J, Li Y, Kong L, Hu Q. Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology 2010;51:1555-66. [DOI: 10.1002/hep.23524] [Cited by in Crossref: 84] [Cited by in F6Publishing: 77] [Article Influence: 7.0] [Reference Citation Analysis]
129 Marcolin E, San-Miguel B, Vallejo D, Tieppo J, Marroni N, González-Gallego J, Tuñón MJ. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. J Nutr 2012;142:1821-8. [PMID: 22915297 DOI: 10.3945/jn.112.165274] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 10.0] [Reference Citation Analysis]
130 Wu SJ, Tam KW, Tsai YH, Chang CC, Chao JC. Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats. Am J Chin Med. 2010;38:99-111. [PMID: 20128048 DOI: 10.1142/s0192415x10007695] [Cited by in Crossref: 73] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
131 López-Lázaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 2008;52 Suppl 1:S103-27. [PMID: 18496811 DOI: 10.1002/mnfr.200700238] [Cited by in Crossref: 46] [Cited by in F6Publishing: 111] [Article Influence: 3.3] [Reference Citation Analysis]
132 Aggarwal BB, Sundaram C, Malani N, Ichikawa H. CURCUMIN: THE INDIAN SOLID GOLD. In: Aggarwal BB, Surh Y, Shishodia S, editors. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Boston: Springer US; 2007. pp. 1-75. [DOI: 10.1007/978-0-387-46401-5_1] [Cited by in Crossref: 817] [Cited by in F6Publishing: 716] [Reference Citation Analysis]
133 Sarkar FH, Li Y, Wang Z, Kong D. NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol. 2008;27:293-319. [PMID: 18853341 DOI: 10.1080/08830180802276179] [Cited by in Crossref: 149] [Cited by in F6Publishing: 145] [Article Influence: 11.5] [Reference Citation Analysis]
134 Locatelli I, Sutti S, Vacchiano M, Bozzola C, Albano E. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses. Clin Sci (Lond) 2013;124:279-87. [PMID: 22970906 DOI: 10.1042/CS20120289] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
135 Jadeja RN, Devkar RV. Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis. Polyphenols in Human Health and Disease. Elsevier; 2014. pp. 615-23. [DOI: 10.1016/b978-0-12-398456-2.00047-5] [Cited by in Crossref: 12] [Article Influence: 1.5] [Reference Citation Analysis]
136 Moseley RH. Liver and biliary tract disorders. Curr Opin Gastroenterol 2006;22:193-7. [PMID: 16550032 DOI: 10.1097/01.mog.0000218954.17570.06] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
137 Wilson DM, Di Gialleonardo V, Wang ZJ, Carroll V, Von Morze C, Taylor A, Sai V, VanCriekinge M, Bok R, Ohliger MA, Keshari KR. Hyperpolarized 13C Spectroscopic Evaluation of Oxidative Stress in a Rodent Model of Steatohepatitis. Sci Rep 2017;7:46014. [PMID: 28425467 DOI: 10.1038/srep46014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
138 Lee SJ, Kang JH, Iqbal W, Kwon OS. Proteomic analysis of mice fed methionine and choline deficient diet reveals marker proteins associated with steatohepatitis. PLoS One 2015;10:e0120577. [PMID: 25849376 DOI: 10.1371/journal.pone.0120577] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]